|
IL2-BASED IMMUNOTHERAPY FOR TYPE 2 DIABETES |
1R43DK109749-01 |
CHEN, RIDONG |
NIDDK |
2016 |
|
A LOW-COST MICROSCALE IMPLANTABLE WIRELESS GLUCOSE SENSOR FOR DIABETES MANAGEMENT |
1R43DK111001-01 |
HONARVAR NAZARI, MEISAM |
NIDDK |
2016 |
|
ENABLING IMPLANTABLE ARTIFICIAL PANCREAS PUMPS WITH HEAT-STABLE, ULTRA-RAPID INSULIN |
1R43DK111003-01 |
FRANK, BRUCE HILL |
NIDDK |
2016 |
|
UNIVERSITY OF WASHINGTON USDRN CLINICAL CENTER (UWCC) |
1U01DK110954-01 |
HARPER, JONATHAN D. |
NIDDK |
2016 |
|
HARNESSING BEHAVIOR TO DECREASE URINARY STONE DISEASE MORBIDITY RESEARCH PROJECT |
1U01DK110961-01 |
TASIAN, GREGORY EDWARD |
NIDDK |
2016 |
|
1/1 URINARY STONE DISEASE WASHINGTON UNIVERSITY RESEARCH NETWORK |
1U01DK110986-01 |
LAI, HING HUNG HENRY |
NIDDK |
2016 |
|
OPTIMIZING FLUID THERAPY AND STENT MANAGEMENT IN CHILDREN AND ADULTS WITH NEPHROLITHIASIS |
1U01DK110994-01 |
MAALOUF, NAIM M |
NIDDK |
2016 |
|
COMPARATIVE EFFECTIVENESS OF BIOFEEDBACK, SACRAL NERVE STIMULATION, AND INJECTABLE BULKING AGENTS FOR TREATMENT OF FECAL INCONTINENCE |
1U34DK109191-01 |
WHITEHEAD, WILLIAM E |
NIDDK |
2016 |
|
CLINICAL ACCEPTANCE OF THE ARTIFICIAL PANCREAS: THE INTERNATIONAL DIABETES CLOSED LOOP (IDCL) TRIAL |
1UC4DK108483-01 |
KOVATCHEV, BORIS P. |
NIDDK |
2016 |
|
THE CONSEQUENCES OF REPEAT EXPANSION IN THE FRAGILE X-RELATED DISORDERS |
1ZIADK057602-20 |
USDIN, KAREN P. |
NIDDK |
2016 |